General Information
Lilly Migraine CGAH
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients with Episodic Migraine – the EVOLVE-2 Study
| Protocol | I5Q-MC-CGAH |
|---|---|
| Identifier | Site Number: 174 PO # 4900533334 |
| UID | 5f57b0dc-a41b-4ddd-aeda-ee8444041396 |
| Status | Done - Archived |
| Phase | 3 |
| Category | Migraine / Adult |
| Launch Year | 2015 |
| NCT Number | - |
| Created | 2015-09-28 10:29 |
| Last Updated | 2015-09-28 10:29 |
Description
No description provided.
Comment
No comment.
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | 2016-07-21 | No |
| Enrollment Open | 2015-12-16 | No |
| First Patient First Visit | No | |
| Site Initiation Mtg. | 2015-12-15 | No |
| PI Meeting Start | No | |
| PI Meeting End | No | |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | 2017-11-07 | No |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Martinez, Gilbert | GJMartinez | No |
| Recruiter | - | No | |
| Coordinator | Sandoval, Larry | LSandoval | No |
| Regulatory | Perez, Myrna | MPerez | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | Eli Lilly and Company |
|---|---|
| Division | Lilly |
| Team | Lilly |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | |
|---|---|
| CRO | Inventiv Health Clinical, LLC |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Gainsboro |
| Currency | - |
